• gmp-verlag.de
  • GMP Compliance Adviser Login
  • Shopping cart
Stay informed!

You’d like to be regularly informed on the latest developments in Good Manufacturing Practices?

 

Subscribe to our free GMP Newsletter LOGFILE!

>>> REGISTER NOW

GMP Compliance Adviser

GMP in Practice: 24 chapters written by internationally renowned industry experts.

 

GMP Regulations: 8 chapters with the most important GMP guidelines and regulations.

 

Image

>>> READ MORE

Award for the
GMP Compliance Adviser

GMP knowledge that convinces.

Image

On 7 June 2016 Maas & Peither GMP Publishing has received a

SIPAward in the category
"Best New Success Story" and was awarded with the 3rd place.

The GMP MANUAL (now: GMP Compliance Adviser) impressed the jury with "Safe Drugs through Better GMP Understanding".


TOP 5 GMP Downloads

1. Questionnaire for preparing GMP-inspections
More than 650 typical questions related to audits and inspections.


2. GMP Fundamentals
A quick and comprehensive overview of the complex world of GMP.


3. GDP Audit Questionnaire
More than 700 questions with reference to regulations.


4. A Pharma Guide to Cleaning Validation
How to meet Agency Expectations and Establish Accepted Limits.


5. Data Integrity in the EU
Requirements for Quality Management Systems.


>>> More Downloads

News about GMP/cGMP

2018-06-15

WHO: Technical Report Series No.1010 published

With the publication of the 52nd Technical Report Series No. 1010 of the WHO, eleven Guidelines were adopted and recommended for use:

 

In the area of Quality Assurance – GMP:
  • WHO guidelines on good herbal processing practices for herbal medicines (Annex 1)
  • WHO good manufacturing practices for herbal medicines (revision) (Annex 2)
  • Guidelines on good manufacturing practices for heating, ventilation and air-conditioning systems (revision) (Annex 8)
  • Guidance on good practices for desk assessment of compliance with good manufacturing practices, good laboratory practices and good clinical practices for medical products regulatory decisions (Annex 9)
  • Stability testing of active pharmaceutical ingredients and finished pharmaceutical products (revision) (Annex 10)
And furthermore:
  • Considerations for requesting analysis of medicines samples (revision) (Annex 3)
  • WHO model certificate of analysis (revision) (Annex 4)
  • WHO guidance on testing of “suspect” falsified medicines (Annex 5)
  • Good pharmacopoeial practices: Chapter on compounding (Annex 6)
  • Good pharmacopoeial practices: Chapter on monographs on herbal medicines (Annex 7)
  • Collaborative procedure in the assessment and accelerated national registration of pharmaceutical products and vaccines approved by stringent regulatory authorities (Annex 11).
Clicking here takes you directly to TRS 1010, that summarises and interprets all results of the 52nd WHO-Expert-Meeting of October 2017 in Geneva. The final guidelines are listed in form of annexes and will be published on the WHO website in form of single documents shortly.
Source:

Comments
No comment has yet been written about this news.